Protara Therapeutics (TARA) Accumulated Depreciation (2013 - 2025)

Protara Therapeutics' Accumulated Depreciation history runs 10 years deep, the most recent figure standing at $1.5 million for Q4 2025.

• In Q4 2025, Accumulated Depreciation rose 32.73% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $1.5 million (up 32.73% YoY), while the FY2025 annual figure was $1.5 million, up 32.73% from the prior year.
• Accumulated Depreciation was $1.5 million for Q4 2025 at Protara Therapeutics, up from $1.1 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $1.5 million in Q4 2025 to a low of $824000.0 in Q4 2023.
• Historically, Accumulated Depreciation has averaged $1.1 million across 3 years, with a median of $1.1 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation surged 34.22% in 2024, then soared 32.73% in 2025.
• A 3-year view of Accumulated Depreciation shows it stood at $824000.0 in 2023, then soared by 34.22% to $1.1 million in 2024, then jumped by 32.73% to $1.5 million in 2025.
• The last three Accumulated Depreciation figures came in at $1.5 million (Q4 2025), $1.1 million (Q4 2024), and $824000.0 (Q4 2023), per Business Quant data.